Mark Stanley Berger's Net Worth

$1.41 Million

Estimate Recalculated Feb 21, 2024 04:49PM EST

Who is Mark Stanley Berger?

Mark Stanley Berger has an estimated net worth of $1.41 Million. This is based on reported shares across multiple companies, which include Actinium Pharmaceuticals, Inc., and Genprex, Inc..

SEC CIK

Mark Stanley Berger's CIK is 0001700283

Past Insider Trading and Trends

2018 was Mark Stanley Berger's most active year for acquiring shares with 4 total transactions. Mark Stanley Berger's most active month to acquire stocks was the month of February. 2018 saw Mark Stanley Berger paying a total of $209,725.00 for 278,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Actinium Pharmaceuticals, Inc. (ATNM) Snapshot price: $5.29

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 1
Form 4
—
0
—
—
0
Aug 12
Form 4
—
0
—
—
0
Jul 12
Form 4
+18.42%
3.5K
$0.60
$2,100.00
22.5K
Mar 5
Form 4
—
0
—
—
0
Jul 13
Form 4
+280.00%
14K
$0.50
$7,000.00
19K
Mar 6
Form 4
∞
5K
$1.11
$5,550.00
5K
Jun 15
Form 3
—
0
—
—
0
No matching records found

Genprex, Inc. (GNPX) Snapshot price: $5.3299

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-21.53%
-1.32K
$4.40
-$5,803.60
4.81K
Feb 18
Form 4
∞
245K
—
—
245K
Feb 18
Form 4
—
0
—
—
0
Feb 4
Form 4
—
0
—
—
0
Sep 27
Form 3
—
0
—
—
0
No matching records found